Siblings Conference Papers/Meeting Abstract [5/7] Collection Statistics Item counts issued in 3 years:2(7.41%) Items With Fulltext:27(100.00%) Download counts of the item Download times greater than 0:27(100.00%) Download times greater than 100:26(96.30%) Total Bitstream Download Counts:12061(85.86%) Last Update: 2024-12-03 04:35 Top Upload Loading... Top Download Loading... Recent Submissions Oncogenic ASPM is a regulatory hub ... ASPM activates Hedgehog and Wnt sig... A Novel Invadopodia-Specific Marker... A novel invadopodia-specific marker... A multi-mode Wnt- and stemness-regu... A multi-mode Wnt- and stemness-regu... Dishevelled 1-regulated superpotent... A multicenter, phase I/II trial of ... Histone demethylase KDM4C stimulate... The differential distributions of A...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 11-20 of 27. (3 Page(s) Totally) << < 1 2 3 > >> View [10|25|50] records per page

Date	Title	Relation
2019-11-13	Histone demethylase KDM4C stimulates the proliferation of prostate cancer cells via activation of AKT and c-Myc	Cancers. 2019 Nov 13;11(11):Article number 1785.
2019-07	Targeting the interplay between cancer fibroblasts, mesenchymal stem cells, and cancer stem cells in desmoplastic cancers	Frontiers in Oncology. 2019 Jul;9:Article number 688.
2019-05-17	Next viable routes to targeting pancreatic cancer stemness: Learning from clinical setbacks	Journal of Clinical Medicine. 2019 May 17;8(5):Article number 702.
2019-02	ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling	Oncogene. 2019 Feb;38(8):1340-1353.
2019-02	ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.]	Oncogene. 2019 Feb;38(8):1354.
2017-11	Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma	Biochemical and Biophysical Research Communications. 2017 Nov;493(1):14-19.
2017-05	Metronomic chemotherapy: Direct targeting of cancer cells after all?	Trends in Cancer. 2017 May;3(5):319-325.
2016-12	Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells	Journal of Experimental Medicine. 2016 Dec;213 (13):2967-2988.
2015-09	Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers	Oncotarget. 2015 Sep;6(27):23987-24001.
2014-07	Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression	Breast Cancer Research. 2014 Jul;16(4):Article number 410.

Showing items 11-20 of 27. (3 Page(s) Totally) << < 1 2 3 > >> View [10|25|50] records per page